PSMB3P2

Across TCGA pan-cancer cohorts, PSMB3P2 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated PSMB3P2 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher PSMB3P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PSMB3P2 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.

PAAD, HNSC, and LUAD are the cancer types where PSMB3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.322	0.509	.004	75	view →
HNSC	OS	Tertile	All	0.369	0.660	<.001	58	view →
LUAD	DFS	Tertile	II,III,IV	0.372	0.646	<.001	52	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	45	view →
BLCA	OS	Tertile	II,III,IV	0.702	0.576	.018	34	view →
SKCM	DFS	Tertile	IV	0.033	0.503	<.001	27	view →
LGG	OS	Tertile	All	0.820	0.926	.013	24	view →
SARC	OS	Tertile	All	0.725	0.862	.002	24	view →
LUSC	DFS	Quartile	All	0.850	0.716	.008	19	view →
UCS	DFS	Tertile	III,IV	0.147	0.423	.041	18	view →
STAD	DFS	Tertile	All	0.459	0.651	.006	13	view →
THCA	OS	Tertile	IV	0.872	1.000	.009	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

PSMB3P2–PAAD (DFS)

Open the PAAD breakdown →